Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis
Author:
Publisher
Hindawi Limited
Subject
General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2011.02633.x/fullpdf
Reference43 articles.
1. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data;Lopez;Lancet,2006
2. ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mansia;Blood Press,2007
3. Heart failure;Jessup;N Engl J Med,2003
4. Angiotensin II receptors and angiotensin II receptor antagonists;Timmermans;Pharmacol Rev,1993
5. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension;Gradman;Hypertension,1995
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Spain;REC: interventional cardiology (English Edition);2024-08-19
2. Catheter-Based Radiofrequency Renal Denervation in the United States: A Cost-Effectiveness Analysis Based on Contemporary Evidence;Journal of the Society for Cardiovascular Angiography & Interventions;2024-08
3. Interaction between Nuclear Receptor and Alpha‐Adrenergic Agonist Subtypes in Metabolism and Systemic Hemodynamics of Spontaneously Hypertensive Rats;PPAR Research;2024-01
4. Cost-effectiveness of neuromuscular electrical stimulation for the treatment of mild obstructive sleep apnea: an exploratory analysis;International Journal of Technology Assessment in Health Care;2023
5. Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2;Molecules;2022-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3